FindTrial
Sign In

A personalised approach for tobacco cessation to reduce smokeless tobacco use

Culturally adapted behavioural support for smokeless tobacco cessation- a randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098481
Enrollment
208
Registered
2025-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F172- Nicotine dependence

Interventions

Intervention1: Behavioural intervention for smokeless tobacco cessation in adults (BISCA): The BISCA intervention pack comprises an adviser flipbook, a client booklet and a self-help calendar for smok

Sponsors

Multi-Disciplinary Research Unit Regional Institute of Medical Sciences, Imphal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. exclusive user of ST products daily (more than 25 days per month during the past 6 months) 2. provide written, informed consent 3. express motivation to quit ST in the next month

Exclusion criteria

Exclusion criteria: 1. Dual tobacco users (reporting smoking along with ST use in the past month, or having a carbon monoxide (CO) concentration more than 10 parts per million) on a breath test 2. already receiving treatment for tobacco cessation

Design outcomes

Secondary

MeasureTime frame
Biochemically validated abstinence verified by CO breath test (less than 10ppm) and salivary cotinine assessment (less than 15ng/ml)Timepoint: 26 weeks—

Primary

MeasureTime frame
Self-reported 7-day point prevalence of tobacco use at Timepoint: 6, 12 and 26 weeks—

Countries

India

Contacts

Public ContactNandita Kshetrimayum

Regional Institute of Medical Sciences

drnanditak@gmail.com7085970502

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026